Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meta-analysis of single agents in the chemotherapy of NSCLC: what do we want to know?

× No keyword cloud information.

19 in total

1. No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis.

Authors: Ming Yin; Jingrong Yan; Alexandra Voutsina; Carmelo Tibaldi; David C Christiani; Rebecca S Heist; Rafael Rosell; Richard Booton; Qingyi Wei
Journal: Lung Cancer Date: 2010-11-13 Impact factor: 5.705

Review 2. Cost of lung cancer: a methodological review.

Authors: Laurent Molinier; Christophe Combescure; Cristos Chouaïd; Jean-Pierre Daurès; Bruno Housset; Didier Fabre; Alain Grand; Alain Vergnenègre
Journal: Pharmacoeconomics Date: 2006 Impact factor: 4.981

Review 3. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.

Authors: Sharad Mangal; Wei Gao; Tonglei Li; Qi Tony Zhou
Journal: Acta Pharmacol Sin Date: 2017-05-01 Impact factor: 6.150

4. Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.

Authors: Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal: Med Oncol Date: 2017-03-22 Impact factor: 3.064

5. A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer.

Authors: Muhammad Zubair Afzal; Konstantin Dragnev; Keisuke Shirai
Journal: J Thorac Dis Date: 2018-06 Impact factor: 2.895

Review 6. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.

Authors: Zhigang Cui; Zhihua Yin; Xuelian Li; Wei Wu; Peng Guan; Baosen Zhou
Journal: BMC Cancer Date: 2012-02-17 Impact factor: 4.430

7. Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).

Authors: Masaaki Kawahara; Harue Tada; Akihiro Tokoro; Satoshi Teramukai; Hideki Origasa; Kaoru Kubota; Tetsu Shinkai; Masanori Fukushima; Kiyoyuki Furuse
Journal: BMC Cancer Date: 2011-08-17 Impact factor: 4.430

Review 8. Platinum drugs in the treatment of non-small-cell lung cancer.

Authors: J Cosaert; E Quoix
Journal: Br J Cancer Date: 2002-10-07 Impact factor: 7.640

Review 9. Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.

Authors: Mantang Qiu; Xin Yang; Jingwen Hu; Xiangxiang Ding; Feng Jiang; Rong Yin; Lin Xu
Journal: PLoS One Date: 2013-08-19 Impact factor: 3.240

10. Economics of the clinical management of lung cancer in France: an analysis using a Markov model.

Authors: C Chouaïd; L Molinier; C Combescure; J P Daurès; B Housset; A Vergnenègre
Journal: Br J Cancer Date: 2004-01-26 Impact factor: 7.640